HERPES SIMPLEX VIRUS-1 IGG (CLIA) - INVIMA Registration c0d8a3418db201cb131b63757f404ee6
Access comprehensive regulatory information for HERPES SIMPLEX VIRUS-1 IGG (CLIA) (HERPES SIMPLEX VIRUS-1 IGG (CLIA)) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID c0d8a3418db201cb131b63757f404ee6 and manufactured by MINDRAY MEDICAL COLOMBIA S.A.S.. The device was registered on December 21, 2033.
This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
EL ENSAYO DE LA IGG DEL VIRUS DEL HERPES SIMPLE 1 DE LA SERIE CL ES UN INMUNOENSAYO QUIMIOLUMINISCENTE (CLIA) PARA LA DETERMINACIÓN CUALITATIVA DE IGG FRENTE AL VIRUS DEL HERPES SIMPLE TIPO 1 EN SUERO Y PLASMA HUMANOS. LA PRUEBA ESTÁ DISEÑADA PARA COMPLEMENTAR EL DIAGNÓSTICO DE UNA INFECCIÓN RECIENTE O ACTUAL CAUSADA POR EL VIRUS DEL HERPES SIMPLE TIPO 1 Y EVALUAR EL ESTADO INMUNITARIO DE PACIENTES, INCLUIDAS LAS MUJERES EMBARAZADAS.
THE CL SERIES HERPES SIMPLEX VIRUS 1 IGG ASSAY IS A CHEMILUMINESCENT IMMUNOASSAY (CLIA) FOR THE QUALITATIVE DETERMINATION OF IGG AGAINST HERPES SIMPLEX VIRUS TYPE 1 IN HUMAN SERUM AND PLASMA. THE TEST IS DESIGNED TO SUPPLEMENT THE DIAGNOSIS OF A RECENT OR CURRENT INFECTION CAUSED BY HERPES SIMPLEX VIRUS TYPE 1 AND TO ASSESS THE IMMUNE STATUS OF PATIENTS, INCLUDING PREGNANT WOMEN.